scholarly journals Voriconazole-warfarin interaction necessitating warfarin dose management in an invasive aspergillosis patient: A case report

2020 ◽  
Vol 6 (1) ◽  
pp. 12-15
Author(s):  
Kai Song ◽  
Moo Hyun Kim ◽  
Jia Xin Li ◽  
Xuan Jin
Keyword(s):  
Case Report ◽  
Invasive Aspergillosis ◽  
Warfarin Dose ◽  
Warfarin Interaction ◽  
Dose Management

scholarly journals INVASIVE ASPERGILLOSIS INVOLVING MULTIPLE PARANASAL SINUSES – A CASE REPORT

2005 ◽  
Vol 23 (3) ◽  
pp. 195-197
Author(s):  
S Agarwal ◽  
A Kanga ◽  
V Sharma ◽  
DR Sharma ◽  
ML Sharma
Keyword(s):  
Case Report ◽  
Invasive Aspergillosis ◽  
Paranasal Sinuses

scholarly journals Fulminant invasive aspergillosis of the mediastinum in an immunocompetent host: a case report

2012 ◽  
Vol 6 (1) ◽  
Author(s):  
Muhammad Tariq Shakoor ◽  
Samia Ayub ◽  
Zunaira Ayub ◽  
Faisal Mahmood
Keyword(s):  
Case Report ◽  
Invasive Aspergillosis ◽  
Immunocompetent Host

scholarly journals Maxillary sinus aspergillosis: A case report of the timely failure to treatment

2019 ◽  
Author(s):  
Asma Beyki ◽  
Mahmud Zardast ◽  
Zahra Nasrollahi
Keyword(s):  
Case Report ◽  
Invasive Aspergillosis ◽  
Maxillary Sinus ◽  
Paranasal Sinuses ◽  
Tooth Extraction ◽  
Histopathological Examination ◽  
Maxillary Sinusitis ◽  
Eye Pain ◽  
Lower Jaw ◽  
The Right

Invasive aspergillosis of the paranasal sinuses is a rare and often misdiagnosed disease. This study reported a case of max- illary aspergillosis with a complete  headache and eye pain after tooth extraction with a large abscess in the relative jaw. Tenderness in the right temporal, lower jaw numbness and right eye proptosis was found. Histopathological examination was the suggestion of maxillary sinusitis with a fungal ball of aspergillus.

scholarly journals Invasive aspergillosis presenting as hilar masses with stenosis of bronchus: A case report

2019 ◽  
Vol 7 (22) ◽  
pp. 3832-3837
Author(s):  
Shan-Shan Su ◽  
Ying Zhou ◽  
Han-Yan Xu ◽  
Ling-Ping Zhou ◽  
Cheng-Shui Chen ◽  
...  
Keyword(s):  
Case Report ◽  
Invasive Aspergillosis

Invasive aspergillosis of sphenoidal sinus in a patient in Djibouti, revealed by palsy of cranial nerves: a case report

2013 ◽  
Vol 23 (2) ◽  
pp. 217-220
Author(s):  
A. Crambert ◽  
J. Gauthier ◽  
R. Vignal ◽  
C. Conessa ◽  
B. Lombard
Keyword(s):  
Case Report ◽  
Invasive Aspergillosis ◽  
Cranial Nerves ◽  
Sphenoidal Sinus

Warfarin dose adjustment required after cannabidiol initiation and titration

2020 ◽  
Vol 77 (22) ◽  
pp. 1846-1851
Author(s):  
Josh Cortopassi
Keyword(s):  
Case Report ◽  
Interaction Potential ◽  
Significant Interaction ◽  
Dose Adjustment ◽  
Intractable Epilepsy ◽  
Warfarin Dose ◽  
International Normalized Ratio ◽  
Dose Titration ◽  
Published Report ◽  
Clinically Significant

Abstract Purpose A case of a possible interaction between cannabidiol and warfarin is presented along with a brief overview of cytochrome enzymes involved in these drugs’ metabolism. Summary A 46-year-old male taking warfarin for treatment of a deep venous thrombosis was initiated on a Food and Drug Administration (FDA)–approved cannabidiol product (Epidiolex, Greenwich Biosciences) for intractable epilepsy. The patient’s International Normalized Ratio (INR) was monitored closely during cannabidiol initiation and dose titration. The patient required a nearly 20% warfarin dose reduction to maintain an INR within the goal range after starting therapy with cannabidiol. There is 1 other case report describing a clinically significant interaction between cannabidiol (specifically Epidiolex) and warfarin in a patient receiving warfarin who was enrolled in a study involving the initiation and titration of cannabidiol; that patient developed a supratherapeutic INR of 6.86 and required a 30% reduction in the weekly warfarin dose to reachieve the goal INR. Conclusion A previously published report suggesting an interaction between cannabidiol and warfarin is supported by this case report. INR should be monitored frequently in patients taking warfarin who begin to take FDA-approved cannabidiol. Additional studies should be performed to clarify the interaction potential of cannabidiol and warfarin.

Sign in / Sign up

Export Citation Format

Share Document